Background. The verification and identification of the transplanted pancreas rejection type requires a morphological examination of the
Introduction
Pancreas transplantation (PT) is one of the treatment methods for patients with type 1 diabetes mellitus suffering from end-stage chronic renal disease. If the glomerular filtration rate is reduced <20 ml/min/1.73 m² or if the patient is already receiving renal replacement therapy, a combined kidney and pancreatoduodenal complex (PDC) transplantation or DD transplantation after previous kidney transplantation is indicated [1] .
According to different authors, a 1-year pancreas graft (PG) survival rate reaches 95% [2] , a 5-year graft survival ranges from 69% to 80% [3] . It was noted that the causes of PDC function loss differ in different time periods after transplantation. So, the main etiological factors of PDC dysfunction during the first week after surgery include the surgical complications (vascular thromboses), and the immunological ones (acute graft rejection).
The most significant factors of the functional loss a week later after transplantation include the infectious complications, and a PDC rejection a month later posttransplant [4] .
In PDC transplantation, the rejection is diagnosed based on the criteria reflecting the PG functional status, such as the blood levels of amylase and lipase, glycemia, C-peptide, etc. To diagnose an acute rejection, some instrumental methods may also be useful: radionuclide scintigraphy, angiography, Doppler ultrasonography (US), magnetic resonance imaging (MRI), and computed tomography. But none of these methods is reliably 4 specific. Verification and evaluation of the rejection type requires a morphological examination of the graft tissue. A transcutaneous biopsy of PG is associated with a high risk of surgical complications that may be accompanied by infectious complications and the risk of graft loss. Much safer is the PDC duodenal mucosa (DDM) biopsy. Earlier it was possible only by using the method of bladder drainage: the pancreas transplantation with draining the exocrine secretions into the urinary bladder. In literature, one can find the works of American scientists where they used a large number of such biopsies to show a correlation of changes in the PDC DDM with the development of the PG rejection [5] . According to the international registry, from 10% to 28% of patients who were operated on earlier by using that technique subsequently had to be subjected to relaparotomy and reconstructive surgery to divert the exocrine secretion into the bowel due to the development of urological and metabolic complications. The purpose of the study was to evaluate the efficacy of the morphological study of DDM for early diagnosis of PG acute rejection crisis (ARC).
Material and methods
The study presents a retrospective analysis of 35 DDM biopsies made in 19 recipients. The number of biopsies performed at different time points after PDC transplantation is presented in Table. 1. Six patients who had indirect signs of PDC dysfunction at the time of the study were included in the main group, and 7 patients who had no clinical or laboratory abnormalities at the time of the study made up the comparison group. 7 We should note that in 9 (47.4%) of 19 patients, the biopsy was made 2 or more times to assess the treatment efficacy or in routine examinations.
To diagnose the rejection and to assess its severity, the histological examination included the evaluation of a number of parameters: intestinal villi condition, the presence of goblet cells, the brush border state, the presence and extent of stroma infiltration, lamina muscularis mucosa, the presence of ulcer defects, vessel condition, and the presence of apoptotic bodies.
For a morphological study, the biopsy material was fixed in a 10%
formalin solution, embedded in paraffin; the sections were stained with hematoxylin and eosin. A histochemical PAS reaction was used to evaluate the basal lamina, and the MSB reaction was used to detect vascular abnormalities.
Statistical processing of the study results was performed using descriptive statistics methods. The groups were compared using Fisher's exact test. The significance level threshold was assumed equal to 0.05.
Results
The (ARC) signs were seen in 18 DDM biopsies (51.4%) of 12 recipients (63.2%). Mild or slightly pronounced ARC episodes were the most commonly detected (n = 13, 72.2%). Moderate ARC was seen in 3 biopsy specimens (16.6%), severe ARC was seen in 2 (11.1%). The timing of the ARC onset is presented in Table 2 .
8 Table 2 Apoptotic bodies were identified in 2 biopsy specimens (15.4%) (Fig. 2) . In the comparison group, the correction of immunosuppressive therapy was required in one case (14.3%) due to failed attempts to achieve the target calcineurin concentration in blood (conversion from tacrolimus to cyclosporine). Two other recipients received anti-crisis therapy for the ARC of the renal graft that was diagnosed alongside the morphological signs of 13 the rejection reaction in DDM. In all the cases, the transplanted PDC function remained satisfactory.
In a retrospective data analysis, we found that the patients with detected PDC ARC had the following signs of PG dysfunction at the time of taking DDM biopsy:
-Two patients had clinical signs. In both cases, a severe ARC was noted. The crisis was manifested by a severe pain syndrome in the early postoperative period in one patient, by clinical signs of acute pancreatitis (abdominal pain, nausea, vomiting) in the other patient.
-The instrumental studies most commonly detected abnormal characteristics of intraorgan blood flow in PG with increased resistance indices in 4 cases (22.2%).
-Increased levels of the following laboratory parameters were observed: blood total amylase and pancreatic amylase in 7 patients (38.9%), This method of identifying immunologic complications might be associated with overestimated diagnosis of pancreatoduodenal complex acute rejection because the duodenum is rich in lymphoid tissue and therefore appears to be more immunogenic than the pancreas. Therefore, even if a pancreatoduodenal complex rejection is found to be mild, but without clinical manifestations, there is no need to prescribe anti-crisis therapy, and the correction of the baseline immunosuppression is quite sufficient.
Conclusions
Donor DDM biopsy serves as an important criterion in the diagnosis of an acute rejection crisis the pancreatoduodenal complex, while it is a safe invasive diagnostic method, even in the earliest postoperative period.
1. Donor DDM biopsy should be included in the routine examination of the patients who underwent pancreas transplantation with creation of duodeno-duodenoal anastomosis, both in the early and late postoperative periods.
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